Direct cardiac effects of a novel vesamicol receptor ligand, m- iodobenzyl-trozamicol, assessed in the canine isolated, blood-perfused heart preparations

Journal of Cardiovascular Pharmacology

Volumn 34, Issue 6, 1999, Pages 843-847

  Sugiyama, Atsushi ^a   Lurie, Keith G ^b   Efange, Simon M N ^c   Takehana, Shunji ^a   Hashimoto, Keitaro ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Chronotropic; Coronary vasodilator; Inotropic; MIBT; Monophasic action potential; Vesamicol

Indexed keywords

3 (IODOBENZYL)TROZAMICOL; UNCLASSIFIED DRUG; VESAMICOL DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC ACTIVITY; CHRONOTROPISM; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; DOG; DOSE RESPONSE; FEMALE; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL;

ACTION POTENTIALS; ANIMALS; CORONARY CIRCULATION; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART; HEART RATE; HEART VENTRICLES; IODOBENZENES; LIGANDS; MALE; MYOCARDIAL CONTRACTION; PAPILLARY MUSCLES; PERFUSION; PIPERIDINES; RECEPTORS, CHOLINERGIC; SINOATRIAL NODE; VASODILATION;

EID: 0032706276     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199912000-00011     Document Type: Article

References (14)

1. Coffeen PR, Efange SMN, Haidet GC, et al. Measurement of functional cholinergic innervation in rat heart with a novel vesamicol receptor ligand. Nucl Med Biol 1996;23:923-6.
2. 125I] MIBT): potential radioligand for mapping central cholinergic innervation. J Med Chem 1993;36:1754-60.
3. Marshall IG, Parsons SM. The vesicular acetylcholine transport system. Trends Neurol Sci 1987;10:174-7.
4. 125I] MIBT in primate brain. Eur J Pharmacol 1997:338:159-69.
5. Endoh M, Hashimoto K. Pharmacological evidence of autonomic nerve activities in canine papillary muscle. Am J Physiol 1970; 218:1459-63.
6. Kubota K, Hashimoto K. Selective stimulation of the parasympathetic preganglionic nerve fibers in the excised and blood-perfused SA node preparation of the dog. Naunyn Schmiedebergs Arch Pharmacol 1973;278:135-50.
7. Sugiyama A, Kobayashi M, Tsujimoto G, Motomura S, Hashimoto K. The first demonstration of cGRP-immunoreactive fibers in canine hearts: coronary vasodilator, inotropic and chronotropic effects of CGRP in canine isolated blood-perfused heart preparations. Jpn J Pharmacol 1989;50:421-7.
8. Sugiyama A, Motomura S, Tamura K, Hashimoto K. Comparison of cardiovascular effects of pirmenol with those of disopyramide in isolated canine heart preparations cross-circulated with a donor dog. Jpn J Pharmacol 1990;53:97-110.
9. Sugiyama A, Motomura S, Hashimoto K. Comparison of cardiovascular effects of a novel class Ic antiarrhythmic agent, NIK-244 with those of flecainide in isolated canine heart preparations cross-circulated with a donor dog. Jpn J Pharmacol 1991;56:1-12.
10. Sugiyama A, Motomura S, Hashimoto K. Utilization of an isolated, blood-perfused canine papillary muscle preparation as a model to assess efficacy and adversity of class I antiarrhythmic drugs. Jpn J Pharmacol 1994;66:303-16.
11. Sugiyama A, Xue YX, Hagihara A, Saitoh M, Hashimoto K. Characterization of magnesium sulfate as an antiarrhythmic agent. J Cardiovasc Pharmacol Ther 1996;1:243-54.
12. Ansel GM, Coyne K, Arnold S, Nelson SD. Mechanisms of ventricular arrhythmia during amitriptyline toxicity. J Cardiovasc Pharmacol 1993;22:798-803.
13. Sugiyama A, Aye NN, Katahira S, et al. Effects of nonsedating antihistamine, astemizole, on the in situ canine heart assessed by cardiohemodynamic and monophasic action potential monitoring. Toxicol Appl Pharmacol 1997;143:89-95.
14. Sugiyama A, Hashimoto K. Effects of gastrointestinal prokinetic agents, TKS159 and cisapride, on the in situ canine heart assessed by cardiohemodynamic and electrophysiological monitoring. Toxicol Appl Pharmacol 1998;152:261-9.